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ABSTRACT 
 
 
Measures of respiratory symptoms and function have been studied in two 
successive generations over a 25 year period, based on a larger original cohort of 
15,411 men and women aged 45-64 and a subsequent family study comprising 
2298 adult sons and daughters aged 30-59 from 1477 families. Poor respiratory 
health is a dominant feature of the original cohort, in association with high rates of 
socio-economic deprivation and mortality rates from all causes. Measures of 
chronic obstructive pulmonary disease (COPD), such as the MRC chronic 
bronchitis questionnaire, hospital admissions and death certification, 
underestimate the contribution of measured respiratory impairment to poor health 
and premature mortality. Cigarette smoking within families is a predictor of future 
ill health in family members, as shown by the associations between passive 
smoking and cardiorespiratory health in cohabiting adults and between maternal 
smoking and reduced FEV1 in adult offspring. The prevalences of chronic sputum 
production and cigarette smoking have fallen between the generations, while the 
prevalences of hay fever and atopic asthma increased. These trends and the 
aggregation of respiratory impairment within families provide many opportunities 
for further investigation. 
 
INTRODUCTION 
 
 
The Renfrew and Paisley (MIDSPAN) Study is one the longest–running 
prospective population studies in the world and spans two generations of adults 
living in west central Scotland. Poor cardio-respiratory health has been a 
dominant feature of the study population and has given rise to many important 
and original observations. This paper provides a brief overview of the study and a 
review and commentary on the main respiratory findings. 
 
 
 
METHODS 
 
 
Study populations 
 
The original study cohort recruited 7058 men and 8353 women aged 45-64, 
between 1972 and 1976, comprising 80% of the general population in this age 
group in the two towns of Renfrew and Paisley. The towns are adjacent to the 
south-west border of the city of Glasgow, within the large, post-industrial, 
Clydeside population, which is characterised by high levels of socio-economic 
deprivation and premature mortality. 
 
The original cohort included 4064 married couples, who were contacted in 1995 
either directly or via dearth certificate informants, to seek information on the 
number, dates of birth and current addresses of all natural offspring. Addresses 
were available for 3445 couples, of whom 2841 replied, providing the names and 
addresses of 4829 offspring aged 30-59, from 2365 couples with children. 3202 
offspring from 1767 couples lived locally and formed the eligible population for a 
second study. In 1996, 1040 male and 1298 female offspring from 1477 families 
participated (the response rate for individuals was 73% and for families was 
84%). 
 
Measurements 
 
Both studies included comprehensive questionnaires and physical 
measurements, for which the methods have been described previously (1-3). 
Data common to both studies include assessments of cigarette smoking, 
responses to the MRC bronchitis and Rose chest pain questionnaires, and 
measurements of blood pressure, cholesterol, body mass index and 
electrocardiography. A large number of other variables were measured in blood 
samples taken from offspring (4). Stored DNA is available for 2225 offspring and 
556 surviving parents. Reported and recorded birthweights are available for 1714 
and 678 offspring respectively. 
 
Forced expiratory volume in one second (FEV1) was measured in the original 
cohort (5) using a Garthur Vitalograph (best of two expirations with the subject 
standing) and in the offspring study using a Fleisch pneuomtachograph and 
American Thoracic Society (ATS) standards to define spirogram acceptability (6). 
The spirometer’s calibration was checked before every session. To improve 
spirometric quality, technicians were given performance feedback. A total of 2294 
subjects attempted spiromtery of whom 2195 (96%) provided at least two ATS 
acceptable curves. Between-visit coefficients of variation for FEV1 and FVC were 
3%. 
 
Predicted values of FEV1 were obtained separately in each generation from 
linear regressions on age and height in healthy men and women who had never 
smoked and who did not have asthma (2,5,7). 
 
Follow-up 
All participants have been followed up for all cause and disease-specific mortality, 
cancer incidence and hospital admissions. Deaths reported in this manuscript 
have been coded to ICD9. 
 
 
RESULTS 
 
Baseline findings in the original cohort 
Over 80% of men in every age group had smoked at some stage of their lives. 
25% were ex-smokers when studied in 1972-76, 54% women had smoked, but 
only 7% had stopped by the time of the study (1). 
 
The age-related prevalence of chronic bronchitis, defined according to the MRC 
questionnaire, rose from 3.6% in men aged 45-49 to 8.9% in men aged 60-64. 
Compared with the figures for chronic bronchitis, more than twice as many men 
were breathless on effort while walking with people of their own age on level 
ground. Overall, 13.6% of men reported breathlessness and 5.9% reported 
symptoms of chronic bronchitis (1). 
 
16.4% of women were breathless when walking with people of their own age on 
level ground, compared with 4.1% who had symptoms of chronic bronchitis. The 
youngest women had higher levels of breathlessness on effort compared with 
men (15.7% v 8.8%). The oldest men aged 60-64 had higher levels of chronic 
bronchitis than women at this age (8.9% v 4.4%). Otherwise, there only small 
gender differences in these variables. The prevalences of chronic bronchitis and 
breathlessness both showed strong social class gradients. 
 
The prevalences of chronic bronchitis and other symptoms of respiratory 
impairment were higher than in other populations studied at the same time, 
including the Whitehall Study of Civil Servants, the Tecumseh Community Health 
Study and the WHO Collaborative Study of employed men (8). Prevalence rates 
in Renfrew were also higher than the prevalences observed some ten years later 
in rural and more affluent urban settings in Scotland (Scottish Heart Health Study, 
unpublished data). 
 
FEV1 fell with age and showed strong social class gradients in men and women 
(1).  
 
Follow-up of original cohort 
 
Dividing men and women separately into fifths of the distributions of 
observed/predicted FEV1, relative hazard ratios for mortality after 15 years were 
highest in the bottom quintile, not only for respiratory causes of death, but also for 
every other major category of death, including ischaemic heart disease, lung 
cancer, stroke and other causes (5). This pattern of observation persisted after 
excluding deaths within the first five years of follow-up, and was also found in life-
long non-smokers. 
 
Reduced FEV1 was second only to cigarette smoking (in terms of percentage 
population attributable risk for all cause mortality in men and women), ranking 
substantially higher than blood pressure, social class and cholesterol. In this 
study, FEV1 was the most important physical measurement for predicting 
premature death (4) 
 
Hospital use 
 
Between 1972 and 1995, 79% of the cohort experienced at least one acute 
hospital stay, with an average of 4.6 episodes per person and a mean length of 
stay per episode of 11.9 days (reducing from 13.8 days in 1975 to 5.6 days in 
1995). Follow-up of hospital admission data showed that disease of the 
respiratory system provided the principal diagnosis for 5.1% of hospital 
admissions. Individuals in the lowest quartile of FEV1 measurement were 27% 
more likely to be admitted than those in the top quartile, 50% more likely to have 
a “serious” admission and 98% more likely to have a hospital admission resulting 
in death (9) 
 
Death certificates 
In the 25 years following the initial study, 4267 men (61%) and 3746 women 
(45%) died (Table 1). Respiratory deaths ranked fourth in men (9.3%) after 
coronary heart disease, cancer and stroke, and fourth in women (8.4%) after 
cancer, coronary heart disease and stroke. COPD deaths comprised 49% of 397 
respiratory deaths in men and 43% of 315 respiratory deaths in women. 
 
Passive smoking 
The high response rates in the original study meant that there was often more 
than one participant per household (10). Passive smoking could be studied, 
therefore, on the basis of a lifelong non-smoking index case and whether the 
cohabitee had ever smoked or never smoked. Symptoms of breathlessness and 
excess sputum production were increased in passive smokers, although these 
findings did not reach statistical significance. Forced expiratory volume in one 
second, adjusted for covariates was significantly lower in passive smokers than in 
controls. All cause mortality was also higher in passive smokers, as were all 
causes of death related to smoking and mortality from lung cancer and ischaemic 
heart disease. A dose-response relationship was found, based on the amount of 
cigarettes smoked by the co-habitee. 
 
Inter-generational trends 
Comparing age standardised prevalences of respiratory illness, smoking and 
social class at age 45-54 years, the percentage of current smokers fell between 
1972-6 and 1996 from 55% in fathers to 26% in sons, and from 52% in mothers 
to 24% in daughters (3). The percentage with chronic sputum production fell from 
24% in fathers to 14% in sons and from13% in mothers to 7% in daughters. The 
proportion of participants in non-manual occupations rose from 32% in fathers to 
55% in sons, and from 47% in mothers to 77% in daughters. 
 
In never smokers, age and sex standardised prevalences of asthma and hay 
fever were 3.0% and 5.8% respectively in 1972-6, rising to 8.2% and 19.9% in 
1996. In ever smokers, the corresponding values were 1.6% and 5.4% in 1972-6 
and 5.3% and 15.5% in 1996. In both generations, the prevalence of asthma was 
higher in those who reported hay fever (atopic asthma). In never smokers, reports 
of wheeze not labelled as asthma were about 10 times more common in 1972-76 
than in 1996. With a broader definition of asthma (asthma and/or wheeze) to 
minimise diagnostic bias, the overall prevalence of asthma changed little. 
However, diagnostic bias mainly affected non-atopic asthma. Atopic asthma 
increased more than twofold (prevalence ratio 2.52) whereas the prevalence of 
non-atopic asthma did not change (1.00). 
 
Effect on offspring FEV1 of parental death from COPD 
Analysis of FEV1 values for male offspring who smoked, and with a parent who 
had died of COPD, showed striking reductions in FEV1 compared to controls 
(Table 2). In cases with COPD mentioned anywhere on the death certificate, the 
average reduction in FEV1 in offspring was 235 ml. In cases with COPD 
mentioned as the underlying cause of death, the decrement was 255 ml. 
Confining these analyses to parental deaths under 70 gave decrements of 319 ml 
with any mention of COPD on the death certificate and 478 ml with COPD 
mentioned as the underlying cause of death.  
 
Familial aggregation of FEV1 
 
Strict comparison  and interpretation of trends in spirometric data between the 
two studies is not possible, because of the different measurement methods 
employed. It is possible, however, to rank individuals within generation-specific 
distributions and to observe the nature and extent of familial aggregation of 
FEV1. 
 
The prevalence of high FEV1 (a value in the top quintile) was highest (41%) in 
the adult offspring of parents who both had high FEV1, while the prevalence of 
low FEV1 (a value in the bottom quintile) was highest (37%) in the offspring of 
parents who both had low FEV1 (Figure 1). However, there are exceptions. 6% of 
the adult offspring of parents with high FEV1 had low personal values of FEV1, 
while 7% of the adult offspring of parents who both had low FEV1 had high 
personal values of FEV1. Such observations, and investigation and comparison 
of offspring from the different categories may help to explain why respiratory 
impairment runs in some families but not others, and why some individuals 
appear to “escape” the phenotype shared by their parents. 
 
Early origins of adult disease 
 
An early analysis based on data from the two generations, showed an inverse 
relationship between maternal smoking and FEV1 in adults (11). Because FEV1 
and FVC are strongly correlated, it was unclear whether the association in 
question reflected a link with lung volume, airflow limitation, or both. This analysis 
was extended, therefore, to investigate whether maternal and personal smoking 
synergise to increase airflow limitation (7). Residual FEV1 was estimated as an 
expression of FEV1 variation that was not associated with FVC. Irrespective of 
personal smoking, maternal smoking was inversely associated with FEV1 and 
FVC, and also FEV1/FVC, forced mid-expiratory flow rates and residual FEV1 in 
current smokers but not in never or former smokers. The clinical relevance of 
these findings was assessed in ever smokers without asthma: 10 cigarettes per 
day of maternal cigarette smoking increased prevalent COPD in offspring by 1.7 
(95% confidence interval 1.2 – 2.5) after adjustment for covariates. Within 
families, the effect of a mother smoking 10 cigarettes per day over twenty years 
previously, has the same effect on airflow limitation in offspring as 10 years of 
personal smoking. Maternal smoking impairs lung volume irrespective of personal 
smoking and appears to synergise with personal smoking to increase airflow 
limitation and COPD. 
 
FEV1 and cardiovascular risk status 
 
In cross-sectional analyses of the offspring generation, taller men and women 
had more favourable cardiovascular profiles than shorter people (12). Leg length 
was the component of adult height most strongly associated with cardiovascular 
risk. Genetic influences did not seem to underlie the height-CHD associations. 
However, FEV1 was more strongly associated than height with the cardiovascular 
risk factors examined, suggesting that it may be a better biomarker for the factors 
underlying associations between pre-adult exposures and adult cardiovascular 
disease. The findings provide indirect evidence that measures of lung 
development and pre-pubertal growth act as biomarkers for childhood exposures 
that may modify an individual’s risk of developing CHD.  
 
Current work is proceeding to assess the effect of new risk factors in explaining 
familial aggregation and disease risk. For example, the strength of the 
association between C-reactive protein (CRP) and cardiovascular disease is 
sufficiently consistent that a recent joint American Heart Association/Center for 
Disease Control statement produced guidelines for its potential incorporation into 
future risk factor stratification (13). In the MIDSPAN offspring, we have shown an 
association between CRP levels and area-based definitions of socio-economic 
deprivation, which is independent of known confounding factors such as age, sex, 
smoking status and obesity (14). It is possible that socio-economic deprivation, as 
assessed by place of residence is associated with an aggregation of features 
which results in an increase in low-grade background systemic inflammation, 
indicated by an increase in the plasma concentration of CRP which is not 
explained by associations with smoking and body mass index. 
 
In a separate analysis we found that after adjusting for potential confounders, 
there was a negative association between birthweight and CRP, whereby a 1kg 
increase in birth weight is associated with a 10.7% decrease in CRP (15). We 
have also observed an inverse relationship between levels of CRP and raw 
FEV1, with more than a doubling of CRP levels between the highest and lowest 
quartiles of FEV1 (unpublished data). 
DISCUSSION 
 
The Renfrew and Paisley general population study is one of the longest running 
prospective studies of cardiorespiratory risk and disease, and is unusual in 
several respects, including its setting in a population with very high levels of 
socio-economic deprivation and premature mortality, its initial 80% coverage of 
this population and the inclusion of similar proportions of men and women. The 
setting in a single locality, combined with relatively low population mobility, has 
also enabled follow up studies, including a major study of adult offspring, using 
similar measurement methods. 
 
The baseline established high levels of respiratory symptoms, in association with 
known risk factors and hazards such as cigarette smoking, short stature and poor 
housing and air quality.  
 
A major finding of the study has been the importance of respiratory impairment, 
as measured by FEV1 and other measures of lung function, comparing observed 
with predicted, in determining future risk of hospital admissions and mortality, not 
only for respiratory diagnoses, but also all other major causes of hospital 
admission and death. The observation of this pattern in life-long non-smokers and 
in people who were free of respiratory symptoms at baseline, and after exclusion 
of deaths within the first five years of follow-up, all point to a general effect of 
respiratory impairment on population health, that is not fully captured by focusing 
on respiratory symptoms and diagnoses. 
 
The pervasive effect of respiratory impairment on mortality is confirmed by the 
observation that the population attributable risks for all cause and for CHD 
mortality were higher for reduced FEV1 than for any other measurable risk factor, 
including blood pressure and cholesterol, and was second only to cigarette 
smoking in terms of overall effect. 
 
The study shows that smoking in the home environment is harmful to other family 
members, not only via the cumulative effects of passive smoking on 
cardiorespiratory symptoms and disease, but also the long term effects on 
respiratory function in adult offspring.  
 
An important feature of the MIDSPAN Family study is that the adult offspring are 
old enough to demonstrate expression of their predisposition and susceptibility to 
adverse behaviours and environments. Thus, a family history of premature 
parental death from COPD is seen to be associated with a substantial reduction 
in FEV1 in adult offspring who smoke, while a history of maternal smoking is 
associated with both an increased prevalence of COPD and reduction of FEV1 in 
adult offspring. 
 
In general, symptoms of COPD are less prevalent in adult offspring than in the 
parent generation, particularly in families who smoke, suggesting improvements 
not only in general health, in association with increased stature and upward social 
mobility, but also in exposure to other respiratory hazards. 
 
At the same time, the study shows a triplng of the prevalence of atopy, based on 
the changing prevalence of hay fever, and a doubling of the prevalence of 
asthma, in both smokers and non-smokers. 
 
Levels of FEV1 are seen to aggregate in families, at both ends of the population 
distribution, but there are fascinating exceptions to the general rule, with “high” 
offspring of “low” parents and vice versa, which call out for further investigation 
and explanation. 
 
The study confirms that FEV1, with height, may be a useful biomarker of future 
susceptibility to cardiovascular risk and disease, representing the combined and 
cumulative effects of early influences on growth and development. The observed, 
separate, associations between C-reactive protein levels and socio-economic 
deprivation, birth weight and FEV1 raise the possibility of an inflammatory basis 
to this early disease predisposition. 
 
Although respiratory impairment is clearly important as a predictor of premature 
mortality and poor health, it is less clear whether any interventions, other than 
smoking cessation, can be employed to improve future outcomes. Until such 
measures become available, population monitoring of respiratory function may 
nevertheless have a useful role to play, in providing a general measure of current 
and future population health. 
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TABLE 1 
 
Ranking of causes of death after 25 years of follow up of 7058 men and 
8353 women aged 45-64 in the Renfrew and Paisley (MIDSPAN) Study 
 
 
 Men     Women 
 
1. Coronary heart disease (36%) Cancer (30%) 
 
2. Cancer (30%)    Coronary heart disease (28%) 
 
3. Stroke (10%)    Stroke (15%) 
 
4. Respiratory (9%)   Respiratory (8%) 
 
5. Other (7%)    Other (9%) 
 
6. Other CVD (6%)   Other CVD (7%) 
 
7. Digestive (2%)   Digestive (3%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2 
 
Decrements of FEV1 in male offspring who smoke,  associated with various 
definitions of COPD death in a parent 
 
 
Family history     Effect on FEV1 (95% CI) 
 
 
COPD anywhere on the death certificate  -235 ml (-64 to –407 ml)  p=0.007 
 
COPD as first cause of death   -255 ml (+36 to –546) p=0.086 
 
COPD anywhere on death certificate  -319 ml (-2 to –636) p=0.049 
Death < 70 years 
 
COPD as first cause of death,   -478 ml (-12 to –943) p=0.044 
Death < 70 years 
 
 
Adjusted for age, maternal smoking, pack years of personal smoking, parental 
social class, parental housing tenure, personal social class, personal housing 
tenure. 
 
 
FIGURE 1 
 
Familial aggregation of FEV 
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